Financial assessment and diagnosis of abnormal data of listed companies in public health and wellness industry

In this study, the present status of the public health and wellness sector in China is examined. The main objective is to evaluate the financial risk among publicly listed companies in the sector. Despite the significant expansion of the industry, research in this domain remains limited. Moreover, it frequently lacks depth, especially when it comes to financial studies designed especially for publicly traded companies. Current models for assessing corporate financial risk are frequently applied in diverse industries without necessary adjustments. Therefore, this study examines the financial performance and operational health of five publicly listed anonymized companies between 2020 and 2023. Using an efficient methodology that includes reliable data collection and quality assurance, we analyze key performance indicators such as annual revenues, liquidity ratios, and debt-to-equity ratios to assess financial stability and growth potential. Our findings reveal varied revenue trends shaped by external market shocks such as the COVID-19 pandemic. These trends highlight both the resilience of the sector and its vulnerabilities. To evaluate potential financial risks and outliers, the abnormal revenue patterns are also identified using Z-score. Benchmarking is also conducted using industry averages which provides a clearer understanding of competitive positioning. Several suggestions are made in light of the analysis to manage debt, increase liquidity, and leverage digital transformation for long-term growth. Several future directions are also presented to continue research in the domain. Overall, this study offers valuable information for stakeholders navigating the complexities of the public health and wellness industry in China.